Congress
John Garamendi
Congressional disclosures describe the filer and reportable household transactions, with amounts in ranges.
Source last checked 2026-10-12 01:31 UTC. Reporting dates appear with the records.
Stock growth & value
Stocks linked to collected disclosures. Prices refresh in the background; the chart shows its actual price dates.
Stock price · move across the chart or use arrow keys
Illustration assumes buying this stock at the first displayed close and holding through the last. It does not represent this person's investment or earnings. Uses stored split-adjusted closing prices, without dividends, fees or taxes. Only mapped USD share positions qualify for firm estimates; options, debt and unmapped holdings are excluded. This chart covers the selected stock.
Congressional transactions
Showing 9 of 9 disclosed transactions. Amounts are reported ranges; family ownership stays attributed.
| Asset | Action | Amount range | Date |
|---|---|---|---|
| TWTRself | sell | $1K – $15K | 2022-01-14 |
| FBspouse | sell | $15K – $50K | 2022-01-14 |
| GVAspouse | sell | $1K – $15K | 2022-01-14 |
| SQspouse | sell | $1K – $15K | 2022-01-14 |
| i c best of my knowledge and belief. Digitally Signed: g f e d c b I CERTIFY that the statements I have made on the attached Periodic Transaction Report are true, complete, and correct to the n m l k j Yes n nitial ertification anD P m l k j i No JT ublic o Hon. John Garamendi , 07/23/2017 Health Fusion FILING s L D oCaTIoN EsCRIPTIoN fferingS S TaTUs ignature : Us : Private placement : Newself | sell | $15K – $50K | 2017-05-15 |
| i c best of my knowledge and belief. Digitally Signed: g f e d c b I CERTIFY that the statements I have made on the attached Periodic Transaction Report are true, complete, and correct to the n m l k j Yes n nitial ertification anD P m l k j i No sP ublic o Hon. John Garamendi , 07/18/2017 solazyme, Inc. (sZYM) F IlING fferingS S s TaTus ignature : Newself | sell | $1K – $15K | 2017-04-21 |
| HealthFusion F l D IlING oCaTIoN EsCRIPTIoN s TaTus : us : sale of stock : Newjoint | sell | $15K – $50K | 2016-01-21 |
| solazyme, Inc. (sZYM) F IlING s TaTus : Newjoint | buy | $1K – $15K | 2016-01-08 |
| HealthFusion F l D options existed IlING oCaTIoN EsCRIPTIoN s TaTus : us : sale of stock options. These were created in the process of the sale of the company. I was unaware that these : Newjoint | sell | $250K – $500K | 2016-01-05 |